Pfizer has been accused of making an "obscene profit" from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year. Pfizer told investors to expect revenue in 2023 to drop by as much as 33 percent; it expects total revenue for the year to be between $67 billion and $71 billion as demand for COVID-related drugs falls off. This is the people's vaccine, but governments have let companies like Pfizer monopolize the technology